7 results for "Halstrom, Amanda"
Showing 1–7 · 0.39 seconds · RSS
-
Journal Article Full text
THU028 Novel Approach To Management Of Acromegaly With De Novo Oral Octreotide Or Combination Therapy With Cabergoline: A Case Series
Disclosure: A. Halstrom: None. G.A. Dobri: None. Acromegaly is a rare disorder characterized by tumoral hypersecretion of growth hormone (GH) leading to overproduction of insulin-like growth factor 1 (IGF-1). Patients present with physical changes, and systemic complications. Treatment involves…
-
Journal Article Full text
Efficacy of Hybrid Closed-Loop Insulin Delivery System in a Hospital Setting: A Case Series
OBJECTIVE: We report a case series of 4 patients with type 1 diabetes who used hybrid closed-loop insulin pumps (Medtronic MiniMed 670 G) during hospitalization. METHODS: Clinical data and point-of-care glucose values are presented for each patient. Glucose values are shown graphically while in…
-
Journal Article Full text
THU040 Different Patient Versus Provider Perspectives On Living With Cushing’s Disease
Disclosure: A. Halstrom: None. I. Lin: None. M. Cohen: None. V. Tabar: None. E.B. Geer: None. Background: Patients with Cushing’s disease (CD) face many challenges living with and receiving appropriate care for this rare, chronic condition. Even with successful treatment, many continue to…
-
Journal Article Full text
Different patient versus provider perspectives on living with Cushing’s disease
CONTEXT: Patients with Cushing’s disease (CD) face challenges living with and receiving appropriate care for this rare, chronic condition. Even with successful treatment, many patients experience ongoing symptoms and impaired quality of life (QoL). Different perspectives and expectations between…
-
Journal Article Full text
Continuous Subcutaneous Insulin Infusions vs. Multiple Daily Injections of Insulin in Hospitalized Patients: Glycemic Trends in the First 24 Hours of Admission
BACKGROUND: Continuous subcutaneous insulin infusion (CSII) is a common diabetes treatment modality. Glycemic outcomes of patients using CSII in the first 24 hours of hospitalization have not been well studied. This timeframe is of particular importance because insulin pump settings are programmed…
-
Journal Article Full text
THU063 Somatostatin Analog Neoadjuvant Treatment Before Endoscopic Surgery For Growth-Hormone Producing Pituitary Adenomas Invading The Cavernous Sinus: Case Series, Systematic Literature Review And Meta-analysis
Disclosure: B. Rapoport: None. A. Halstrom: None. A. Kelly: None. M. Roytman: None. J. Lantos: None. D. Phillips: None. R. Ramakrishna: None. T. Schwartz: None. G.A. Dobri: None. Background: Pituitary surgery remains the first line of treatment for acromegaly, yet 35-50% of patients with…
-
Journal Article Full text
MON-167 Hypoglycemia Prevention: A Quality Improvement Project to Reduce Inpatient Hypoglycemia Rate Following Treatment of Hyperkalemia
Background: The use of fixed doses of intravenous insulin and dextrose for hyperkalemia treatment is well-established. Iatrogenic hypoglycemia as a result of treatment although common, can have negative consequences. Literature reveals various practices to minimize hypoglycemia risk. Aim: Our aim…